Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress
Go back to Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 79.90 -2.1 (2.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.00 | 52 Week High | $8.22 | |||
| Open | $80.00 | 52 Week Low | $3.07 | |||
| Day High | $82.53 | P/E | N/A | |||
| Day Low | $79.69 | EPS | $-1.30 | |||
| Volume | 1,393,506 | |||||
